Trials / Unknown
UnknownNCT02210494
Safety of Secretrol® in the Short-term Management of Patients Undergoing Endoscopic Mucosal Resection (EMR)
Phase 1 Study of Safety of Secretrol® in the Short-term Management of Patients Undergoing Endoscopic Mucosal Resection (EMR)
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 5 (estimated)
- Sponsor
- Effexus Pharmaceutical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate the safety of Secretrol® in patients undergoing endoscopic mucosal resection for early adenocarcinoma of the esophagus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Secretrol |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2015-08-01
- First posted
- 2014-08-06
- Last updated
- 2014-08-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02210494. Inclusion in this directory is not an endorsement.